SAPHNELO
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0310-3080 -
Package NDC
0310-3080-01 -
Package NDC
0310-3080-02 -
Package NDC
0310-3080-95 -
Application number
BLA761451 -
SPL ID
0f042188-8a78-4ed5-b2af-a5b1e75b5f25 -
SPL set ID
d6203302-2128-41a7-b0b4-0e6c0704d4dc -
UNII
38RL9AE51Q -
RxCUI
2565280 -
RxCUI
2565286 -
RxCUI
2741470 -
RxCUI
2741474 -
RxCUI
2741478 -
RxCUI
2741482
What the source publishes
- Labeler
- AstraZeneca Pharmaceuticals LP
- Active ingredients
- Anifrolumab-fnia
- Form
- INJECTION, SOLUTION
- Routes
- SUBCUTANEOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- BLA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "SAPHNELO",
"splId": "0f042188-8a78-4ed5-b2af-a5b1e75b5f25",
"labels": [
{
"setId": "d6203302-2128-41a7-b0b4-0e6c0704d4dc",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d6203302-2128-41a7-b0b4-0e6c0704d4dc",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d6203302-2128-41a7-b0b4-0e6c0704d4dc"
}
],
"routes": [
"SUBCUTANEOUS"
],
"labeler": "AstraZeneca Pharmaceuticals LP",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 SYRINGE, GLASS in 1 CARTON (0310-3080-01) / .8 mL in 1 SYRINGE, GLASS (0310-3080-25)",
"package_ndc": "0310-3080-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20260424"
},
{
"sample": false,
"description": "1 SYRINGE, GLASS in 1 CARTON (0310-3080-02) / .8 mL in 1 SYRINGE, GLASS (0310-3080-75)",
"package_ndc": "0310-3080-02",
"identifierStatus": "well-formed",
"marketing_start_date": "20260424"
},
{
"sample": true,
"description": "1 SYRINGE, GLASS in 1 CARTON (0310-3080-95) / .8 mL in 1 SYRINGE, GLASS (0310-3080-25)",
"package_ndc": "0310-3080-95",
"identifierStatus": "well-formed",
"marketing_start_date": "20260424"
}
],
"productId": "0310-3080_0f042188-8a78-4ed5-b2af-a5b1e75b5f25",
"useDomain": "unknown",
"dosageForm": "INJECTION, SOLUTION",
"productNdc": "0310-3080",
"deaSchedule": null,
"genericName": "Anifrolumab-fnia",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "ANIFROLUMAB",
"strength": "120 mg/.8mL"
}
],
"applicationNumber": "BLA761451",
"marketingCategory": "BLA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20260424",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000193967",
"N0000193968"
],
"unii": [
"38RL9AE51Q"
],
"rxcui": [
"2565280",
"2565286",
"2741470",
"2741474",
"2741478",
"2741482"
],
"spl_set_id": [
"d6203302-2128-41a7-b0b4-0e6c0704d4dc"
],
"pharm_class_epc": [
"Type I Interferon Receptor Antagonist [EPC]"
],
"pharm_class_moa": [
"Type I Interferon Receptor Antagonists [MoA]"
],
"manufacturer_name": [
"AstraZeneca Pharmaceuticals LP"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0310-3080_0f042188-8a78-4ed5-b2af-a5b1e75b5f25"